12:00 AM
 | 
Nov 25, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

NovoEight turoctocog alfa regulatory update

Novo Nordisk said the Committee on Drugs of Japan's Pharmaceutical Affairs and Sanitation Council recommended approval of NovoEight turoctocog alfa to treat hemophilia A. The Ministry of Health, Labor and Welfare...

Read the full 132 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >